Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

19.31
-0.3200-1.63%
Post-market: 19.340.0300+0.16%19:54 EDT
Volume:7.73M
Turnover:148.91M
Market Cap:22.15B
PE:-137.15
High:19.69
Open:19.40
Low:19.07
Close:19.63
52wk High:22.80
52wk Low:12.47
Shares:1.15B
Float Shares:1.14B
Volume Ratio:0.94
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1408
EPS(LYR):-1.4492
ROE:-2.42%
ROA:5.37%
PB:3.24
PE(LYR):-13.32

Loading ...

Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2024

Major Issues Report

Form 8-K - Current report